What the future holds for BHV-1
and BVDV control

Research into designing better BHV-1 and BVD vaccines is likely to continue given the potential economic losses associated with BHV-1 and BVDV infection in cattle. New vaccines may include needle-free vaccination methods, effective single-shot vaccines that extend the duration of immune memory while decreasing the number of adverse vaccine injection sites reactions. The following are criteria for designing BHV-1 and BVDV vaccines:

Conventional vaccines are not the most ideal design for safe, cost-effective and efficient protection against BVD and BHV-1, however their effectiveness can be manipulated by means already discussed in the BVD and BHV-1 vaccination sections. The way of the future is in the hands of subunit and DNA vaccines that have the potential to deliver efficient, safe, and immunologically relevant protection.